Omada Health CEO sells 14,960 shares in plan

Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported an open-market sale of 14,960 shares of common stock on June 16, 2026 at an average price of $17.3604 per share.

Rhea-AI Filing Summary

Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported an open-market sale of 14,960 shares of common stock on June 16, 2026 at an average price of $17.3604 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026, indicating it was pre-scheduled.

Following the sale, Duffy directly holds 411,861 shares of Omada Health common stock. In addition, 851,659 shares are held indirectly in family trusts for the benefit of his family members, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary 10b5-1

Net Seller: 14,960 shares

Net Sell 2 txns

Insider Duffy Sean P.

Role Chief Executive Officer

Sold 14,960 shs ($260K)

Type	Security	Shares	Price	Value
Sale	Common Stock	14,960	$17.3604	$260K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 411,861 shares (Direct); Common Stock — 851,659 shares (Indirect, See footnote)

Footnotes (2)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. F2. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

Key Figures

Shares sold: 14,960 shares Sale price: $17.3604 per share Direct holdings after sale: 411,861 shares +2 more

5 metrics

Shares sold 14,960 shares Open-market sale of common stock on June 16, 2026

Sale price $17.3604 per share Average price for 14,960 shares sold

Direct holdings after sale 411,861 shares Common stock directly held by CEO after transaction

Indirect trust holdings 851,659 shares Shares held in family trusts for CEO’s family members

Net shares sold 14,960 shares Net-sell direction in transaction summary

Key Terms

Rule 10b5-1 trading plan, open-market sale, family trusts, pecuniary interest

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action: open-market sale, code S for sale in open market"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

family trusts financial

"Held in family trusts for the benefit of the Reporting Person's family members."

pecuniary interest financial

"disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) report for CEO Sean P. Duffy?

Omada Health reported that CEO Sean P. Duffy sold 14,960 shares of common stock. The sale occurred on June 16, 2026 in an open-market transaction at an average price of $17.3604 per share.

Was the Omada Health (OMDA) CEO share sale made under a 10b5-1 trading plan?

Yes. The filing states the transaction was made under a Rule 10b5-1 trading plan. This plan was adopted on March 13, 2026, meaning the sale was pre-arranged rather than a discretionary market-timing decision.

How many Omada Health (OMDA) shares does CEO Sean P. Duffy hold after the sale?

After the transaction, Sean P. Duffy directly holds 411,861 shares of Omada Health common stock. The filing also reports 851,659 shares held indirectly in family trusts, where he disclaims beneficial ownership except for any pecuniary interest.

What price did the Omada Health (OMDA) CEO receive per share in the reported sale?

The reported open-market sale was executed at an average price of $17.3604 per share. This price applies to the 14,960 shares of Omada Health common stock sold in the transaction dated June 16, 2026.

How are the indirect Omada Health (OMDA) holdings of the CEO structured?

The filing notes 851,659 shares are held in family trusts for the benefit of Sean P. Duffy’s family members. He disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in the trusts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:18 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duffy Sean P.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		S(1)		14,960	D	$17.3604	411,861	D
Common Stock								851,659	I	See footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

	/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)